West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 456,100 | 469,700 | 443,500 | 422,500 | 431,700 |
| Cost of Goods | 308,300 | 311,800 | 296,700 | 289,300 | 296,100 |
| Gross Profit | 147,800 | 157,900 | 146,800 | 133,200 | 135,600 |
| Operating Expenses | 80,800 | 78,200 | 76,800 | 67,700 | 74,900 |
| Operating Income | 67,300 | 80,500 | 70,700 | 65,800 | 60,800 |
| Interest Expense | 2,100 | 2,000 | 2,300 | 2,300 | 2,000 |
| Other Income | 2,000 | 3,100 | 3,100 | 3,400 | 4,400 |
| Pre-tax Income | 67,200 | 81,600 | 71,500 | 66,900 | 63,200 |
| Income Tax | 10,900 | 15,500 | 16,100 | 14,900 | 8,000 |
| Net Income Continuous | 56,300 | 66,100 | 55,400 | 52,000 | 55,200 |
| Net Income | $56,300 | $66,100 | $55,400 | $52,000 | $55,200 |
| EPS Basic Total Ops | 0.76 | 0.90 | 0.75 | 0.70 | 0.75 |
| EPS Basic Continuous Ops | 0.76 | 0.90 | 0.75 | 0.70 | 0.75 |
| EPS Diluted Total Ops | 0.75 | 0.88 | 0.73 | 0.68 | 0.73 |
| EPS Diluted Continuous Ops | 0.75 | 0.88 | 0.74 | 0.69 | 0.73 |
| EBITDA(a) | $92,600 | $106,800 | $96,200 | $92,100 | $87,000 |